These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 126434)

  • 21. Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase.
    Schwarzenberg L; Mathé G; Pouillart P; Weiner R; Locour J; Genin J; Schneider M; De Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Br Med J; 1973 Mar; 1(5855):700-3. PubMed ID: 4512003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of priapism in patients with chronic granulocytic leukemia.
    Schreibman SM; Gee TS; Grabstald H
    J Urol; 1974 Jun; 111(6):786-8. PubMed ID: 4524674
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP; Shah GB
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract]   [Full Text] [Related]  

  • 24. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
    Perreau P; Gardais J
    Sem Hop; 1969 Mar; 45(15):964-70. PubMed ID: 4307171
    [No Abstract]   [Full Text] [Related]  

  • 25. Improved therapy for chronic granulocytic leukemia.
    Spiers AS
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):370-82. PubMed ID: 367387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recent concepts of chronic myeloid leukemia and its treatment].
    Bousser J; Bilski-Pasquier G; Zittoun
    Bull Mem Soc Med Hop Paris; 1966 May 6-20; 117(8):665-74. PubMed ID: 5224894
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic granulocytic leukemia cutis treated with hydroxyurea. Report of a case.
    Friedhoff FW; Atamer MA; Thelmo WL
    Chemotherapy; 1978; 24(5):321-6. PubMed ID: 276447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.
    Das KV; Thomas M; Pilla MV; Vijayakumar
    J Assoc Physicians India; 1977 Aug; 25(8):547-53. PubMed ID: 275251
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of busulphan non-responsive chronic myeloid leukaemia.
    Roul RK; Singh AD
    J Indian Med Assoc; 1982 Aug; 79(3):27-9. PubMed ID: 6960081
    [No Abstract]   [Full Text] [Related]  

  • 31. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V
    Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Cancer; 1972 Apr; 29(4):1052-6. PubMed ID: 4552811
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic myelogenous leukemia--new concepts (second of two parts).
    Koeffler HP; Golde DW
    N Engl J Med; 1981 May; 304(21):1269-74. PubMed ID: 7012625
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chronic myelocytic leukemia: apparent "recovery" for over nine years, following therapeutic medullary hypoplasia. A clinical and cytogenetic study].
    Mauruce PA; Ferrier S; Alberto P; Freund M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1781-2. PubMed ID: 5291101
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase.
    Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J
    Przegl Lek; 1969; 25(3):305-9. PubMed ID: 4182966
    [No Abstract]   [Full Text] [Related]  

  • 37. New trends in the management of chronic myeloid leukaemia.
    Tura S
    Haematologica; 1972 Apr; 57(11):741-52. PubMed ID: 4200309
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of chronic leukaemia.
    Shaw S
    Practitioner; 1970 Jun; 204(224):773-9. PubMed ID: 5271298
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic myelogenous leukemia: a clinical and experimental evaluation of splenectomy and intensive chemotherapy.
    Brodsky I; Fuscaldo KE; Kahn SB; Conroy JF; Lamping CG
    Ser Haematol; 1975; 8(4):143-56. PubMed ID: 798283
    [No Abstract]   [Full Text] [Related]  

  • 40. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
    Wagner H; McKeough PG; Desforges J; Madoc-Jones H
    Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.